America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
A new study shows CFOs report productivity boosts from AI, but revenue gains lag behind, hinting at a one-year delay ...
Iran has quietly formalized yuan-based fees for ships passing the Strait of Hormuz as U.S. forces position nearby. Th...
The U.S. Postal Service has filed for an 8% temporary price increase on Priority Mail and other core services to offs...
With whispers of funded shortfalls, retirees social security just may face tighter benefits. This guide breaks down w...
SoFi stock faces a controversial short-seller narrative. This guide explains what that means, how to evaluate the cla...
A practical, beginner-friendly blueprint to aim for $100 per month in super-safe dividend income using two dependable...
A single 2019 decision helped Oracle pivot from legacy database vendor to an AI-ready cloud player. This article brea...
Cardano just caught major regulatory clarity, a development that could reduce some risk for investors. This guide bre...
A major tech firm is aggressively buying back shares while insiders pile in. This article breaks down what it signals...
GLP-1 drugs like Ozempic and Wegovy are changing the cost landscape for retirees. This guide breaks down what Medicar...
BNB slips on a brief pullback, but longer-term momentum remains constructive as rising moving averages and a quiet re...